source
- BioNTech appoints Sobi CEO Guido Oelkers as new chief, founders to launch separate mRNA biotechBioNTech announced that Guido Oelkers, current chief executive of Swedish Orphan Biovitrum (Sobi), will assume the role of CEO in early 2027. The move follows the earlier decision of co‑founders U…
- Biologics surge drives CMOs and CDMOs to boost sterile fill-finish and prefilled syringe capacityBiologics, biosimilars and GLP-1 therapies are increasing demand for sterile injectable products, prompting contract manufacturers to expand capacity. CMOs and CDMOs are adding fill-finish, lyophi…